JP2021508691A5 - - Google Patents

Info

Publication number
JP2021508691A5
JP2021508691A5 JP2020534610A JP2020534610A JP2021508691A5 JP 2021508691 A5 JP2021508691 A5 JP 2021508691A5 JP 2020534610 A JP2020534610 A JP 2020534610A JP 2020534610 A JP2020534610 A JP 2020534610A JP 2021508691 A5 JP2021508691 A5 JP 2021508691A5
Authority
JP
Japan
Prior art keywords
composition according
receptor
item
cell
ptgfrn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020534610A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021508691A (ja
JP7507090B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/068062 external-priority patent/WO2019133934A2/en
Publication of JP2021508691A publication Critical patent/JP2021508691A/ja
Publication of JP2021508691A5 publication Critical patent/JP2021508691A5/ja
Priority to JP2023125551A priority Critical patent/JP2023133470A/ja
Application granted granted Critical
Publication of JP7507090B2 publication Critical patent/JP7507090B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020534610A 2017-12-28 2018-12-28 免疫腫瘍及び抗炎症療法のためのエクソソーム Active JP7507090B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023125551A JP2023133470A (ja) 2017-12-28 2023-08-01 免疫腫瘍及び抗炎症療法のためのエクソソーム

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762611140P 2017-12-28 2017-12-28
US62/611,140 2017-12-28
US201862723267P 2018-08-27 2018-08-27
US62/723,267 2018-08-27
PCT/US2018/068062 WO2019133934A2 (en) 2017-12-28 2018-12-28 Exosomes for immuno-oncology and anti-inflammatory therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023125551A Division JP2023133470A (ja) 2017-12-28 2023-08-01 免疫腫瘍及び抗炎症療法のためのエクソソーム

Publications (3)

Publication Number Publication Date
JP2021508691A JP2021508691A (ja) 2021-03-11
JP2021508691A5 true JP2021508691A5 (https=) 2022-02-07
JP7507090B2 JP7507090B2 (ja) 2024-06-27

Family

ID=67058801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020534610A Active JP7507090B2 (ja) 2017-12-28 2018-12-28 免疫腫瘍及び抗炎症療法のためのエクソソーム
JP2023125551A Pending JP2023133470A (ja) 2017-12-28 2023-08-01 免疫腫瘍及び抗炎症療法のためのエクソソーム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023125551A Pending JP2023133470A (ja) 2017-12-28 2023-08-01 免疫腫瘍及び抗炎症療法のためのエクソソーム

Country Status (16)

Country Link
US (4) US10723782B2 (https=)
EP (1) EP3731849A4 (https=)
JP (2) JP7507090B2 (https=)
KR (1) KR20200108275A (https=)
CN (2) CN111655271B (https=)
AU (1) AU2018394238A1 (https=)
BR (1) BR112020013131A2 (https=)
CA (1) CA3085471A1 (https=)
CL (1) CL2020001691A1 (https=)
CO (1) CO2020009091A2 (https=)
EA (1) EA202091134A1 (https=)
IL (1) IL275600A (https=)
MX (1) MX2020006672A (https=)
PH (1) PH12020550805A1 (https=)
SG (1) SG11202005049QA (https=)
WO (1) WO2019133934A2 (https=)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019032628A1 (en) 2017-08-07 2019-02-14 The Regents Of The University Of California GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
CN111655271B (zh) 2017-12-28 2025-09-23 隆萨销售股份公司 用于免疫肿瘤学和抗炎疗法的外来体
CA3093856A1 (en) * 2018-03-12 2019-09-19 Board Of Regents, The University Of Texas System Immuno-exosomes and methods of use thereof
EP3775258A4 (en) 2018-03-28 2022-01-26 Board of Regents, The University of Texas System IDENTIFICATION OF EPIGENETIC ALTERATIONS IN DNA ISOLATED FROM EXOSOMES
WO2019199941A1 (en) * 2018-04-10 2019-10-17 Northwestern University Extracellular vesicles comprising targeting affinity domain-based membrane proteins
CA3128386A1 (en) * 2019-02-04 2020-08-13 Codiak Biosciences, Inc. Membrane protein scaffolds for exosome engineering
EP3965829A4 (en) 2019-05-06 2023-05-24 Malcolm, Thomas ADAPTED HYPOIMMUNE NANOVESICULAR DELIVERY SYSTEM FOR CANCER TUMORS
CA3142487A1 (en) 2019-06-04 2020-12-10 Thomas Jefferson University Oligodendrocyte-derived extracellular vesicles for therapy of multiple sclerosis
WO2021003425A1 (en) * 2019-07-03 2021-01-07 Codiak Biosciences, Inc. Methods of inducing hematopoiesis
AU2020309202A1 (en) * 2019-07-05 2021-12-09 Enara Bio Limited Novel cancer antigens and methods
AU2020330133A1 (en) * 2019-08-14 2022-03-17 Lonza Sales Ag Extracellular vesicle-ASO constructs targeting CEBP/beta
CA3147365A1 (en) * 2019-08-14 2021-02-18 Joanne LIM Extracellular vesicle-nlrp3 antagonist
MX2022003570A (es) * 2019-09-25 2022-07-11 Codiak Biosciences Inc Composiciones de vesícula extracelular.
KR20220094221A (ko) 2019-09-25 2022-07-05 코디악 바이오사이언시즈, 인크. 종양의 치료를 위한 il-12 디스플레잉 엑소좀과 조합된 sting 효능제 포함 엑소좀
WO2021076808A1 (en) * 2019-10-15 2021-04-22 Cornell University Methods for detecting and inhibiting brain metastasis
JP7846007B2 (ja) * 2019-12-18 2026-04-14 ノバルティス アーゲー 異常ヘモグロビン症の治療用組成物及び方法
EP4090974A1 (en) 2020-01-17 2022-11-23 Codiak BioSciences, Inc. Cholesterol assays for quantifying extracellular vesicles
EP3858332A1 (en) * 2020-01-31 2021-08-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bottom-up assembly of synthetic extracellular vesicles
JP2023512562A (ja) * 2020-02-05 2023-03-27 ダイアデム バイオセラピューティクス インコーポレイテッド 人工シナプス
KR102688170B1 (ko) * 2020-02-10 2024-07-24 주식회사 엑소스템텍 광 절단성 단백질을 포함하는 엑소좀 및 이의 이용
JP2023518414A (ja) * 2020-03-20 2023-05-01 コディアック バイオサイエンシーズ， インコーポレイテッド 治療のための細胞外小胞
US20230190815A1 (en) 2020-05-11 2023-06-22 Strm.Bio Incorporated Compositions and methods related to megakaryocyte-derived extracellular vesicles
KR102341138B1 (ko) * 2020-05-31 2021-12-21 주식회사 엑소코바이오 엑소좀의 막단백질 변이체를 포함하는 엑소좀 및 이의 제조방법
US20230355803A1 (en) 2020-06-24 2023-11-09 Chameleon Biosciences, Inc. Extracellular vesicles with immune modulators
US20230210910A1 (en) * 2020-07-17 2023-07-06 Dexon Pharmaceuticals Inc. Method for preventing infection of a healthy person or a healthy animal with a virus that uses ace2 as a receptor, binding inhibitor and medical device
JP2023538077A (ja) * 2020-08-17 2023-09-06 コディアック バイオサイエンシーズ， インコーポレイテッド がんの治療方法
US20230355716A1 (en) * 2020-09-04 2023-11-09 Daegu Gyeongbuk Institute Of Science And Technology Method for screening immunogenic anticancer activity cytokine, and composition for preventing or treating cancer disease, comprising il-15 as active ingredient
WO2022140438A1 (en) * 2020-12-22 2022-06-30 Verily Life Sciences Llc Methods for assaying target proteins on extracellular vesicles in plasma
CN112646781B (zh) * 2020-12-25 2023-07-25 广东省人民医院 一种包含人ace2蛋白的外泌体及其应用
CN113040877B (zh) * 2021-03-11 2022-07-22 上海市东方医院（同济大学附属东方医院） 一种基于筋膜间隙理念治疗腹部疾病的输注外泌体系统
CN113462645B (zh) * 2021-03-26 2023-11-28 上海瑞开投资管理有限公司 包含nk细胞和植物来源的外泌体的组合物、其用途及包含其的产品
WO2022215078A1 (en) * 2021-04-07 2022-10-13 Ramot At Tel-Aviv University Ltd. Modified cannabinoids and uses thereof
AU2022264498A1 (en) 2021-04-26 2023-09-28 Strm.Bio Incorporated Compositions and methods related to megakaryocyte-derived extracellular vesicles for fanconi anemia
WO2022250880A1 (en) * 2021-05-25 2022-12-01 Malcolm Thomas Tailored hypoimmune nanovesicular delivery systems for cancer tumors, hereditary and infectious diseases
AU2022315530A1 (en) 2021-07-20 2024-01-18 Ags Therapeutics Sas Extracellular vesicles from microalgae, their preparation, and uses
EP4388314A1 (en) * 2021-08-18 2024-06-26 Universität Duisburg-Essen A biomarker indicating the therapeutic efficacy of extracellular vesicle (ev)-preparations
CN113866413B (zh) * 2021-09-29 2023-05-30 上海市同济医院 一种结直肠癌诊断标志物及其应用
WO2023144127A1 (en) 2022-01-31 2023-08-03 Ags Therapeutics Sas Extracellular vesicles from microalgae, their biodistribution upon administration, and uses
CN114561347A (zh) * 2022-02-25 2022-05-31 和携科技有限公司 一种脂肪间充质干细胞的培养基和培养方法
WO2023195570A1 (ko) * 2022-04-08 2023-10-12 이왕재바이오연구소 주식회사 슈퍼옥시드 디스무타아제를 포함하는 항암 조성물
CN114807023B (zh) * 2022-04-29 2024-03-15 中山大学·深圳 一种细胞膜囊泡及其制备方法与应用
CN114763533B (zh) * 2022-05-17 2024-02-23 深圳市第二人民医院(深圳市转化医学研究院) 外泌体表面原位生长纳米硒的方法及得到的硒化外泌体
KR102788272B1 (ko) * 2022-05-24 2025-04-01 주식회사 시프트바이오 표면-개질된 세포외 소포체 및 이의 치료학적 용도
WO2023232976A1 (en) 2022-06-03 2023-12-07 Ags Therapeutics Sas Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses
CN115047186B (zh) * 2022-06-15 2023-02-14 暨南大学 一种外泌体检测方法
EP4309660A1 (en) 2022-07-18 2024-01-24 Lietuvos Sveikatos Mokslu Universitetas Extracellular vesicles and particles from immune cells for providing anticancer activity
WO2024088808A1 (en) 2022-10-24 2024-05-02 Ags Therapeutics Sas Extracellular vesicles from microalgae, their biodistribution upon intranasal administration, and uses thereof
CN121021708A (zh) * 2023-03-22 2025-11-28 北京恩康医药有限公司 工程化细胞外囊泡
TW202506990A (zh) * 2023-03-30 2025-02-16 艾萬霖生技股份有限公司 放射性標記的外泌體及其製備方法和套組
WO2024249307A1 (en) * 2023-05-26 2024-12-05 H. Lee Moffitt Cancer Center And Research Institute, Inc. Cd40l monomers and methods of their use in til enhancement via ex vivo stimulation
WO2025008357A1 (en) * 2023-07-03 2025-01-09 Institut National de la Santé et de la Recherche Médicale Large extracellular vesicles as biomarkers for predicting organ failures and survival time of patients suffering from an acute decompensation of cirrhosis
CN117018217B (zh) * 2023-10-10 2024-01-30 天津外泌体科技有限公司 Gnai2作为细胞外囊泡支架蛋白的应用、细胞外囊泡及其制备方法和应用
CN117723758B (zh) * 2023-12-14 2024-09-13 陕西脉元生物科技有限公司 检测抗slc3a2自身抗体的试剂在诊断神经系统自身免疫疾病中的应用
WO2025176843A1 (en) 2024-02-21 2025-08-28 Ags Therapeutics Sas Microalgae extracellular vesicle based gene therapy vectors (mev-gtvs), their preparation, and uses thereof
CN118340915A (zh) * 2024-06-13 2024-07-16 北京恩泽康泰生物科技有限公司 一种细胞因子装载系统及制备方法和应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747660A (en) 1995-11-06 1998-05-05 The University Of Colorado Nucleic acid encoding prostaglandin F2α receptor regulatory protein
AU2001275423B2 (en) 2000-06-09 2007-01-11 Regulon, Inc. Encapsulation of polynucleotides and drugs into targeted liposomes
IL160142A0 (en) * 2001-08-17 2004-06-20 Anosys Inc Methods and compounds for the targeting of protein to exosomes
US20040049010A1 (en) 2001-10-26 2004-03-11 Warren Bridget A Transmembrane proteins
US7803906B2 (en) 2002-03-22 2010-09-28 Gene Signal International Sa Composition comprising an angiogenesis related protein
CA2628255C (en) 2005-10-31 2016-04-19 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US9085778B2 (en) 2006-05-03 2015-07-21 VL27, Inc. Exosome transfer of nucleic acids to cells
US20130053426A1 (en) * 2009-04-17 2013-02-28 Yiqi Seow Composition For Delivery Of Genetic Material
AU2011316477A1 (en) 2010-10-11 2013-05-02 Medsaic Pty Ltd Assay for disease detection
WO2013043569A1 (en) * 2011-09-20 2013-03-28 Vical Incorporated Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
US9777042B2 (en) 2011-12-15 2017-10-03 Morehouse School Of Medicine Method of purifying HIV/SIV Nef from exosomal fusion proteins
EP2687219A1 (en) * 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
WO2014082083A1 (en) 2012-11-26 2014-05-30 Caris Science, Inc. Biomarker compositions and methods
EP2840140B2 (en) 2012-12-12 2023-02-22 The Broad Institute, Inc. Crispr-Cas based method for mutation of prokaryotic cells
WO2014138793A1 (en) 2013-03-13 2014-09-18 The University Of Queensland A method of isolating cells for therapy and prophylaxis
WO2015038075A1 (en) * 2013-09-16 2015-03-19 Agency For Science, Technology And Research Method
KR20150043937A (ko) 2013-10-15 2015-04-23 삼성전자주식회사 개체의 간암 진단용 조성물, 개체의 간암 진단하는 방법 및 개체의 간암 진단에 필요한 정보를 얻는 방법
US9921223B2 (en) * 2013-12-04 2018-03-20 Board Of Regents, The University Of Texas System Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
US10772911B2 (en) * 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US20150174166A1 (en) * 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for Cellular Restoration and Methods of Making and Using Same
US20170335281A1 (en) * 2014-03-15 2017-11-23 Novartis Ag Treatment of cancer using chimeric antigen receptor
WO2016057755A1 (en) 2014-10-09 2016-04-14 Anthrogenesis Corporation Placenta-derived adherent cell exosomes and uses thereof
HK1245080A1 (zh) * 2014-10-27 2018-08-24 University Of Central Florida Research Foundation, Inc. 自然杀伤细胞的方法和组合物
WO2016077639A2 (en) 2014-11-12 2016-05-19 VL27, Inc. Nanovesicular therapies
WO2016149358A1 (en) * 2015-03-16 2016-09-22 Duncan Ross Method of treatment comprising membrane-enclosed vesicle
US10427129B2 (en) 2015-04-17 2019-10-01 LLT International (Ireland) Ltd. Systems and methods for facilitating reactions in gases using shockwaves produced in a supersonic gaseous vortex
WO2016168680A1 (en) 2015-04-17 2016-10-20 Exocyte Therapeutics Pte Ltd. Method for developing exosome-based vaccines
WO2016187717A1 (en) * 2015-05-26 2016-12-01 Exerkine Corporation Exosomes useful for genome editing
KR102386735B1 (ko) * 2015-11-06 2022-04-14 주식회사 제넥신 변형된 인터루킨-7 융합 단백질의 제형
EP3397264A4 (en) 2015-12-30 2019-06-05 The Regents of The University of California METHOD FOR IMPROVED PREPARATION AND INSULATION OF CELL-DERIVED VESICLES
CA3017586A1 (en) 2016-03-15 2017-09-21 Codiak Biosciences, Inc. Therapeutic membrane vesicles
US20190125848A1 (en) * 2016-03-30 2019-05-02 Dana-Farber Cancer Institute, Inc. Dendritic cell-extracellular vesicle fusions and methods of using same
US20180128833A1 (en) * 2016-11-08 2018-05-10 Metaclipse Therapeutics Corporation Methods of treating with tumor membrane vesicle-based immunotherapy and predicting therapeutic response thereto
WO2018226758A2 (en) 2017-06-05 2018-12-13 The Regents Of The University Of California Methods for enhanced production and isolation of cell-derived vesicles and treatment of inflammation and neurological damage
IL272786B2 (en) 2017-08-25 2025-03-01 Codiak Biosciences Inc Preparation of therapeutic exosomes using membrane proteins
CN111655271B (zh) 2017-12-28 2025-09-23 隆萨销售股份公司 用于免疫肿瘤学和抗炎疗法的外来体

Similar Documents

Publication Publication Date Title
JP2021508691A5 (https=)
US20260055157A1 (en) Methods of making chimeric antigen receptor-expressing cells
JP7490915B2 (ja) 抗メソテリンキメラ抗原受容体（ｃａｒ）構築物及びその使用
US20210171909A1 (en) Methods of making chimeric antigen receptor?expressing cells
US20200399383A1 (en) Chimeric antigen receptor therapy in combination with il-15r and il15
Casucci et al. Overcoming the toxicity hurdles of genetically targeted T cells
JP2022543702A (ja) ヘテロ接合性の喪失に応答する細胞表面受容体
US20210363218A1 (en) Multispecific chimeric receptors comprising an nkg2d domain and methods of use thereof
JP2020515259A (ja) Ｔ細胞受容体シグナル伝達を阻害または調節することによって、ｔ細胞枯渇を処置する方法
JP7433348B2 (ja) キメラポリペプチド及びそれらの細胞膜における局在を変更する方法
WO2023280307A1 (en) Mutant il-15 compositions and methods thereof
JP7524465B2 (ja) 免疫細胞機能の改善
US12454563B2 (en) Immune cell function
CN116997564A (zh) 改善免疫细胞功能
US20180161369A1 (en) Compositions for cellular immunotherapy
Teschner Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy
JP2025542243A (ja) Ｃａｒ－ｔ細胞を生成するための方法
Norde et al. Role of Co-inhibitory molecules in tumor escape from CTL attack
HK40040870A (en) Immune-enhancing rnas for combination with chimeric antigen receptor therapy